Ziopharm Oncology Appoints Carl June, M.D., as Chairman of Scientific Advisory BoardGlobeNewsWire • 06/15/20
Ziopharm Oncology to Participate in Cell Therapy Panel at the Raymond James Human Healthcare Innovation Conference on June 17, 2020GlobeNewsWire • 06/12/20
ZIOPHARM Oncology, Inc. (ZIOP) CEO Laurence Cooper on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/08/20
ZIOPHARM Oncology, Inc. (ZIOP) CEO Laurence Cooper on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/03/20
Ziopharm Oncology Announces Recent Publications in Peer-Reviewed Scientific JournalsGlobeNewsWire • 01/30/20
Options Traders Expect Huge Moves in ZIOPHARM Oncology (ZIOP) StockZacks Investment Research • 12/30/19
Ziopharm Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 12/09/19
Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Recurrent Glioblastoma at the 2019 Society for Neuro-Oncology Annual MeetingGlobeNewsWire • 11/23/19
Ziopharm Oncology and MD Anderson Cancer Center Announce New R&D Agreement to Expand TCR-T ProgramGlobeNewsWire • 10/28/19
Ziopharm Oncology Names Drug Development Leader Dr. Chris Bowden to Board of DirectorsGlobeNewsWire • 10/15/19
Ziopharm Oncology to Participate in the Morgan Stanley 17th Annual Global Healthcare ConferenceGlobeNewsWire • 08/28/19
ZIOPHARM Oncology, Inc. (ZIOP) CEO Laurence Cooper on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/08/19
ZIOPHARM Oncology, Inc. (ZIOP) CEO Laurence Cooper on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/09/19